Abrams Bison Investments LLC Acquires 800,000 Shares of Acadia Healthcare Company, Inc. $ACHC

Abrams Bison Investments LLC lifted its holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 22.3% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 4,380,000 shares of the company’s stock after purchasing an additional 800,000 shares during the quarter. Acadia Healthcare comprises 8.5% of Abrams Bison Investments LLC’s holdings, making the stock its 5th biggest position. Abrams Bison Investments LLC owned approximately 4.75% of Acadia Healthcare worth $108,449,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of the business. Allworth Financial LP lifted its stake in Acadia Healthcare by 676.4% in the second quarter. Allworth Financial LP now owns 1,351 shares of the company’s stock valued at $31,000 after buying an additional 1,177 shares in the last quarter. EverSource Wealth Advisors LLC increased its position in shares of Acadia Healthcare by 54.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after acquiring an additional 497 shares in the last quarter. Hantz Financial Services Inc. raised its holdings in shares of Acadia Healthcare by 501.9% during the third quarter. Hantz Financial Services Inc. now owns 2,185 shares of the company’s stock worth $54,000 after acquiring an additional 1,822 shares during the period. Quent Capital LLC bought a new stake in Acadia Healthcare in the 3rd quarter valued at $71,000. Finally, Steward Partners Investment Advisory LLC boosted its stake in Acadia Healthcare by 639.5% in the 2nd quarter. Steward Partners Investment Advisory LLC now owns 3,372 shares of the company’s stock worth $77,000 after purchasing an additional 2,916 shares during the period.

Analyst Ratings Changes

Several analysts have issued reports on the company. Barclays lifted their price target on Acadia Healthcare from $14.00 to $20.00 and gave the company an “equal weight” rating in a research note on Tuesday, March 3rd. Zacks Research upgraded Acadia Healthcare from a “strong sell” rating to a “hold” rating in a report on Thursday, March 5th. Deutsche Bank Aktiengesellschaft dropped their target price on Acadia Healthcare from $33.00 to $20.00 and set a “buy” rating on the stock in a research report on Wednesday, December 3rd. Mizuho reduced their price target on Acadia Healthcare from $22.00 to $17.00 and set a “neutral” rating for the company in a research report on Thursday, December 18th. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Acadia Healthcare in a research note on Wednesday, January 21st. Seven investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $21.15.

Acadia Healthcare Stock Performance

ACHC opened at $23.52 on Friday. The business’s 50-day simple moving average is $16.80 and its 200 day simple moving average is $18.76. Acadia Healthcare Company, Inc. has a 52-week low of $11.43 and a 52-week high of $31.04. The company has a debt-to-equity ratio of 1.27, a quick ratio of 1.55 and a current ratio of 1.55. The firm has a market capitalization of $2.17 billion, a PE ratio of -1.93, a PEG ratio of 7.95 and a beta of 0.74.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Wednesday, February 25th. The company reported $0.07 earnings per share for the quarter, beating analysts’ consensus estimates of $0.03 by $0.04. Acadia Healthcare had a positive return on equity of 6.53% and a negative net margin of 33.29%.The firm had revenue of $821.46 million during the quarter, compared to the consensus estimate of $800.10 million. During the same period last year, the company earned $0.64 earnings per share. The business’s revenue was up 6.1% compared to the same quarter last year. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS. As a group, sell-side analysts expect that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Key Stories Impacting Acadia Healthcare

Here are the key news stories impacting Acadia Healthcare this week:

• Positive Sentiment: Acadia added Daniel Cancelmi to its Board of Directors, a governance move that can be viewed positively as expanding board expertise and oversight. Article Title
• Neutral Sentiment: Reported short-interest data shows zero shares and days-to-cover of 0.0 — the release appears to contain anomalous or missing data (NaN/0) and therefore provides no clear signal about bearish positioning.
• Negative Sentiment: Zacks Research cut multiple near-term and multi-year EPS estimates and keeps a “Hold” rating. Key changes include Q2 2026 EPS cut to $0.49 (from $0.66), FY2026 to $1.48 (from $1.85), and FY2027 to $1.55 (from $1.96), plus several quarter-by-quarter reductions across 2026–2027. These downward revisions lower investor expectations and are the main reason for today’s downward pressure on the stock.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.